The effect of Dextromethorphan premedication on cough, pain, anxiety, procedure duration and sedation during fiber optic bronchoscopy.
Phase 2
- Conditions
- Respiratory disorder, unspecified.Respiratory disease (chronic) NOS
- Registration Number
- IRCT2015060520024N2
- Lead Sponsor
- Vice chancellor for research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 66
Inclusion Criteria
1- Any documented indication for diagnostic Fiber Optic Bronchoscopy;
2- Age>18;
Exclusion criteria:
1.Allergy to opioid drugs;
2.Taking sedative drugs during last 48 hours;
3.Pregnant woman;
4.Breastfeeding;
5.Patients with central nervous system diseases;
6.Patients with unstable medical condition;
7.Emergent Fiber Optic Bronchoscopy;
8.Impaired level of consciousness;
9.Intubated patients.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough intensity. Timepoint: during FOB. Method of measurement: Physicians' self assessment score.;Anxiety intensity. Timepoint: during FOB. Method of measurement: Patients' self assessment score.;Lidocaine requirement. Timepoint: during FOB. Method of measurement: Dose of drug recorded by Physician.;Midazolam requirement. Timepoint: during FOB. Method of measurement: Dose of drug recorded by Physician.;Fentanyl requirement. Timepoint: during FOB. Method of measurement: Dose of drug recorded by Physician.;General perception about procedure. Timepoint: during FOB. Method of measurement: Patients' self assessment score.
- Secondary Outcome Measures
Name Time Method General perception about procedure. Timepoint: 2 hours after FOB. Method of measurement: patients' self-assessment score.;Duration of FOB. Timepoint: at the end of FOB. Method of measurement: time in minutes.